Purchases and Sales Made in Q3 2022 in Vor Biopharma Inc. (VOR)
This table provides information about the institutional ownership of Vor Biopharma Inc. (VOR) during Q3 2022. The information is specifically focused on institutions that hold shares of Vor Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Paradigm Biocapital Advisors LP
New York, NY |
BUY
|
- |
399K+ 30.62% |
$1.56M - $2.2M
|
1.7M
$1.89M
|
|
|
Nov 14, 2022
Q3 2022
|
Baker Bros. Advisors LP
New York, NY |
BUY
|
- |
327K+ 28.73% |
$1.28M - $1.81M
|
1.47M
$1.63M
|
|
|
Nov 14, 2022
Q3 2022
|
Ally Bridge Group (Ny) LLC
New York, NY |
BUY
|
- |
255KNew |
$995K - $1.41M
|
255K
$283K
|
|
|
Nov 14, 2022
Q3 2022
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
210KNew |
$817K - $1.16M
|
210K
$233K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
50K+ 17.3% |
$195K - $276K
|
339K
$376K
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
32.9KNew |
$128K - $182K
|
32.9K
$36.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
28.2K+ 26.28% |
$110K - $156K
|
136K
$151K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
25.1K+ 116.9% |
$98.1K - $139K
|
46.7K
$51.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Thrivent Financial For Lutherans
Minneapolis, MN |
BUY
|
- |
15.6K+ 5.42% |
$60.7K - $85.9K
|
302K
$336K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
14.6KNew |
$57K - $80.6K
|
14.6K
$16.2K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
14.6K+ 84.39% |
$56.9K - $80.6K
|
31.9K
$35.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
10.4KNew |
$40.6K - $57.5K
|
10.4K
$11.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
10K+ 14.41% |
$39K - $55.2K
|
79.4K
$88.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
4.1K+ 21.53% |
$16K - $22.6K
|
23.1K
$25.7K
|
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
3.43KNew |
$13.4K - $19K
|
3.43K
$3.81K
|
|
|
Oct 27, 2022
Q3 2022
|
Bourgeon Capital Management LLC
|
BUY
|
- |
3K+ 38.96% |
$11.7K - $16.6K
|
10.7K
$11.9K
|
|
|
Nov 09, 2022
Q3 2022
|
Chicago Partners Investment Group LLC
|
BUY
|
- |
1.66K+ 12.87% |
$6.47K - $9.16K
|
14.5K
$16.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.57KNew |
$6.13K - $8.68K
|
1.57K
$1.74K
|
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
356New |
$1.39K - $1.97K
|
356
$395
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
244+ 16.77% |
$952 - $1.35K
|
1.7K
$1.89K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
40+ 57.14% |
$156 - $221
|
110
$122
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-313- 41.24% |
$1.22K - $1.73K
|
446
$495
|
|
|
Nov 14, 2022
Q3 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-1.46K- 8.98% |
$5.71K - $8.08K
|
14.8K
$16.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2.5K- 0.57% |
$9.74K - $13.8K
|
438K
$486K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-8.47K- 30.76% |
$33K - $46.8K
|
19.1K
$21.2K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-8.47K- 30.76% |
$33K - $46.8K
|
19.1K
$21.2K
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-21.1K- 24.4% |
$82.3K - $116K
|
65.3K
$72.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-22.6K- 74.65% |
$88.1K - $125K
|
7.67K
$8.52K
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-30.6K- 73.78% |
$119K - $169K
|
10.9K
$12.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-42.3K- 24.68% |
$165K - $233K
|
129K
$143K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-57K- 71.78% |
$222K - $315K
|
22.4K
$24.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-722K- 86.58% |
$2.81M - $3.98M
|
112K
$124K
|